Psoriasis Study Pre-Screener Questionnaire
We are recruiting subjects aged 18 to 75 years (inclusive) with plaque psoriasis, to participate in a research study that evaluates the safety of an investigational study drug (XmAb®27564), and how participants with plaque psoriasis react to the investigational study drug when given multiple times. Investigational study drug means it is a drug that has not been approved by the FDA.
Compensation may be provided for time and travel. Participation will come at no cost to you.
Visits: 23.
Study length: 3 month.
Please answer the following questionnaire to the best of your ability. It should takes approximately 4 - 6 minutes to complete.
* Questions with a red star are mandatory.
Start Questionnaire
